These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23640240)

  • 1. Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
    Ulaner GA; D'Andrea G; Cody HS
    Clin Nucl Med; 2013 Jun; 38(6):480-1. PubMed ID: 23640240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
    Hurwitz R
    Clin Nucl Med; 2003 Sep; 28(9):755-6. PubMed ID: 12972998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracapsular breast implant rupture mimicking local cancer recurrence on
    Domínguez ML; Salvat C; F-Llana B; Vigil C; Suárez JP; González FM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):392-394. PubMed ID: 30031678
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive F-18 FDG PET/CT from foreign body reaction on anterior chest wall after endoscopic total thyroidectomy via axillo-breast approach for thyroid cancer: two case reports.
    Jung CH; Kim BY; Kim JW; Lee SW; Kwak JJ; Mok JO; Kim CH; Hong HS; Kang SK; Park JM
    Clin Nucl Med; 2011 Nov; 36(11):1036-8. PubMed ID: 21975398
    [No Abstract]   [Full Text] [Related]  

  • 6. Fat necrosis may mimic local recurrence of breast cancer in FDG PET/CT.
    Akkas BE; Ucmak Vural G
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):105-6. PubMed ID: 22871539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
    Adejolu M; Huo L; Rohren E; Santiago L; Yang WT
    AJR Am J Roentgenol; 2012 Mar; 198(3):W304-14. PubMed ID: 22358030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of FDG PET/CT in the clinical management of breast cancer.
    Groheux D; Espié M; Giacchetti S; Hindié E
    Radiology; 2013 Feb; 266(2):388-405. PubMed ID: 23220901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
    Mathew AS; El-Haddad G; Lilien DL; Takalkar AM
    Clin Nucl Med; 2008 May; 33(5):330-2. PubMed ID: 18431146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET/CT in the diagnosis of recurrent breast cancer.
    Murakami R; Kumita S; Yoshida T; Ishihara K; Kiriyama T; Hakozaki K; Yanagihara K; Iida S; Tsuchiya S
    Acta Radiol; 2012 Feb; 53(1):12-6. PubMed ID: 22067206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Matsunaga N
    Ann Nucl Med; 2009 Jun; 23(4):399-407. PubMed ID: 19452249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
    Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
    Aukema TS; Rutgers EJ; Vogel WV; Teertstra HJ; Oldenburg HS; Vrancken Peeters MT; Wesseling J; Russell NS; Valdés Olmos RA
    Eur J Surg Oncol; 2010 Apr; 36(4):387-92. PubMed ID: 19962268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foreign body reaction from anti-adhesion material during follow-up of gynaecological malignancies: Mimicking local recurrence.
    Kwon YS; Gwack JY; Im KS; Choi DI
    Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):403-7. PubMed ID: 27297456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Palot Manzil FF; Bhambhvani PG
    J Nucl Med Technol; 2018 Dec; 46(4):394-395. PubMed ID: 30076249
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
    Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
    Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging in breast cancer.
    Bombardieri E; Crippa F
    Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
    Suárez M; Pérez-Castejón MJ; Jiménez A; Domper M; Ruiz G; Montz R; Carreras JL
    Q J Nucl Med; 2002 Jun; 46(2):113-21. PubMed ID: 12114874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.